Neuronetics

-$0.06 (-1.87%) As of 5:51 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.

About STIM

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments.

CEO
Keith J. Sullivan
Employees
175
Headquarters
Malvern, Pennsylvania
Founded
2001

STIM Key Statistics

Market cap
84.33M
Price-Earnings ratio
—
Dividend yield
—
Average volume
432.00K
High today
$3.34
Low today
$3.13
Open price
$3.22
Volume
62.46K
52 Week high
$16.25
52 Week low
$1.98

STIM News

Barron'sJun 24

Neuronetics, New Relic Stocks See Action From Activist Investors

Text size These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5

STIM Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure